MOSCOW, 27 Jun – RIA Novosti. Doctors in new York have begun clinical trials of the drug against heartburn famotidine for the treatment of patients with a new type of coronavirus, writes the journal Science.
He added that, if the famotidine is working, it can be used everywhere, because he is “versatile, inexpensive and a lot of it”. According to Tracy, preliminary tests of famotidine may appear in the next few weeks.
during clinical trials the drug is administered to patients intravenously, its dosage is about nine times higher than the dose that must be taken to treat heartburn. To date, the drug is tested on 187 patients, their number is planned to increase to 1200.
the world health organization on 11 March announced the outbreak of a new coronavirus infection COVID-19 pandemic. According to the latest who data, there have been recorded more than 2.8 million cases of infection, more than 193 thousand people died.
the Latest data on the situation of COVID-19 in Russia and the world presented on the portal stopmanager.Russia
